SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Leneweit Gero)
 

Sökning: WFRF:(Leneweit Gero) > Development and cha...

Development and characterization of an innovative heparin coating to stabilize and protect liposomes against adverse immune reactions

Duehrkop, Claudia (författare)
Uppsala universitet,Klinisk immunologi,Uppsala University
Leneweit, Gero (författare)
ABNOBA GmbH, Germany;Association for the Promotion of Cancer Therapy, Germany
Heyder, Christoph (författare)
ABNOBA GmbH, Germany;Association for the Promotion of Cancer Therapy, Germany
visa fler...
Fromell, Karin (författare)
Uppsala universitet,Klinisk immunologi,Uppsala University
Edwards, Katarina (författare)
Uppsala universitet,Analytisk kemi,Uppsala University
Nilsson Ekdahl, Kristina (författare)
Uppsala universitet,Linnéuniversitetet,Institutionen för kemi och biomedicin (KOB),Uppsala University,Linnaeus Ctr Biomat Chem, BMC,Klinisk immunologi
Nilsson, Bo (författare)
Uppsala universitet,Klinisk immunologi,Uppsala University
visa färre...
 (creator_code:org_t)
Elsevier BV, 2016
2016
Engelska.
Ingår i: Colloids and Surfaces B. - : Elsevier BV. - 0927-7765 .- 1873-4367. ; 141, s. 576-583
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Liposomes have been recognized as excellent drug delivery systems, but when they come in direct contact with different blood components they may trigger an immediate activation of the innate immune system. The aim of the present study was to produce long-circulating, blood-compatible liposomes by developing a construct of liposomes covered by a novel unique heparin complex (CHC; 70 heparin molecules per complex) to avoid recognition by the innate immune system. Unilamellar, cationic liposomes were produced by hand extrusion through a 100-nm polycarbonate membrane. Coating of liposomes with the macromolecular CHC was accomplished by electrostatic interactions. Dynamic light scattering as well as QCM-D measurements were used to verify the electrostatic deposition of the negatively charged CHC to cationic liposomes. The CHC-coated liposomes did not aggregate when in contact with lepirudin anti coagulated plasma. Unlike previous attempts to coat liposomes with heparin, this technique produced freely moveable heparin strands sticking out from the liposome surface, which exposed AT binding sites reflecting the anticoagulant potentials of the liposomes. In experiments using lepirudin-anticoagulated plasma, CHC-coated liposomes, in contrast to non-coated control liposomes, did not activate the complement system, as evidenced by low C3a and sC5b-9 generation and reduced leakage from the liposomes. In conclusion, we show that liposomes can be successfully coated with the biopolymer CHC, resulting in biocompatible and stable liposomes that have significant application potential. (C) 2016 Elsevier B.V. All rights reserved.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinsk bioteknologi -- Biomaterialvetenskap (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Medical Biotechnology -- Biomaterials Science (hsv//eng)

Nyckelord

Drug delivery system
Cationic liposomes
Surface coating
Novel heparin complex
Complement system
Biomedical Sciences
Biomedicinsk vetenskap

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy